 Symptomatic treatment versus combination chemotherapy patients extensive non-small cell lung cancer randomized clinical trial patients inoperable extensive non-small cell lung cancer NSCLC combination chemotherapy cisplatin i.v day i.v day days symptomatic treatment significant differences survival time treatment techniques major problem interpretation results use semicurative radiation therapy cGy primary tumor mediastinum symptomatic intent long-term survivors latter group